$CFX : Hong Kong concept + domestic public chain leader, short-term speculation window may open
Recently, Navigation Pharmaceutical Biotechnology Company plans to acquire CFX, attracting market attention. If favorable news follows, it is possible that funds will take the opportunity to speculate on the dual themes of 'Hong Kong stocks + domestic public chains'.
However, it is important to note:
There is heavy selling pressure above CFX, with a dense historical holding position. The project party has previously shown a pattern of 'pump and quick drop'. Mid to long-term opportunities are limited, and long-term holding is not recommended for inexperienced investors.
Short-term trading suggestions:
Pay attention to 'speculative expectation' opportunities during the news fermentation period, choose the right moment to sell high and buy quickly, and do not chase prices.
In simple terms:
This is a short-term speculative market, not a target for long-term belief.
